Efficacy and Safety of Task-activated rTMS in Improving Cognitive Function in Patients With Bipolar Disorder

NARecruitingINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

December 20, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

September 1, 2025

Conditions
Bipolar Disorder
Interventions
DEVICE

Repetitive transcranial magnetic stimulation device

Activating neurons: rTMS can activate or inhibit neuronal activity in certain brain areas, changing the activity pattern of neural networks. Neuroplasticity: By changing the strength and connection mode of synapses, it promotes the plasticity of the nervous system, which helps treat neuropsychiatric diseases. Regulating neurotransmitters: rTMS can regulate the release of neurotransmitters, affect nerve conduction, and thus improve disease symptoms.

Trial Locations (1)

310000

RECRUITING

The First Affiliated Hospital of Zhejiang University, Hangzhou

All Listed Sponsors
lead

First Affiliated Hospital of Zhejiang University

OTHER